Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice

Vascular Pharmacology

Volumn 53, Issue 5-6, 2010, Pages 264-272

  Choi, Sung E ^a   Jang, Hyun Ju ^a   Kang, Yup ^a   Jung, Jong Gab ^a   Han, Seung Jin ^a   Kim, Hae Jin ^a   Kim, Dae Jung ^a   Lee, Kwan Woo ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

ApoE mice; Atherosclerosis; GSK 3; LiCl; Palmitate

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 4 BENZYL 2 METHYL 1,2,4 THIADIAZOLIDINE 3,5 DIONE; APOLIPOPROTEIN E; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; I KAPPA B ALPHA; LITHIUM CHLORIDE; PALMITIC ACID; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA ROOT; AORTA VALVE; ARTICLE; CATALYSIS; CELL INFILTRATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

ANIMALS; AORTIC VALVE; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD GLUCOSE; CELLS, CULTURED; DIET, ATHEROGENIC; DIETARY FATS; ENDOTHELIAL CELLS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INDOLES; LIPID METABOLISM; LITHIUM CHLORIDE; MACROPHAGES; MALE; MALEIMIDES; MICE; MICE, KNOCKOUT; PALMITATES; THIADIAZOLES; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 78349310527     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2010.09.004     Document Type: Article

References (37)

1. Bowes A.J., Khan M.I., Shi Y., Robertson L., Werstuck G.H. Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and GSK-3 in lesion development and hepatic steatosis. Am. J. Pathol. 2009, 174:330-342.
2. Bruunsgaard H., Skinhøj P., Pedersen A.N., Schroll M., Pedersen B.K. Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin. Exp. Immunol. 2000, 121:255-260.
3. Cacicedo J.M., Yagihashi N., Keaney J.F., Ruderman N.B., Ido Y. AMPK inhibits fatty acid-induced increases in NF-?B transactivation in cultured human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 2004, 324:1204-1209.
4. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.C., Connelly P.W., Milstone D.S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 2001, 107:1255-1262.
5. Doble B.W., Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 2003, 116:1175-1186.
6. Dong Y., Zhang M., Wang S., Liang B., Zhao Z., Liu C., Wu M., Choi H.C., Lyons T.J., Zou M.H. Activation of AMP-activated protein kinase inhibits oxidized low density lipoprotein-triggered endoplasmic reticulum (ER) Stress in vivo. Diabetes 2010, 59:1386-1396.
7. Erbay E., Babaev V.R., Mayers J.R., Makowski L., Charles K.N., Snitow M.E., Fazio S., Wiest M.M., Watkins S.M., Linton M.F., Hotamisligil G.S. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat. Med. 2009, 15(12):1383-1391.
8. Jope R.S., Yuskaitis C.J., Beurel E. Glycogen Synthase Kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 2007, 32(4-5):577-595.
9. Kaneto H., Katakami N., Matsuhisa M., Matsuoka T.A. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat. Inflamm. 2010, ID453892. 2010.
10. Kim H.S., Skurk C., Thomas S.R., Bialik A., Suhara T., Kureishi Y., Birnbaum M., Keaney J.F., Walsh K. Regulation of angiogenesis by glycogen synthase kinase-3κ. J. Biol. Chem. 2002, 277:41888-41896.
11. Kim A.J., Shi Y.Y., Austin R.C., Werstuck G.H. Valproate protects cells from endoplasmic reticulum stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase 3. J. Cell Sci. 2005, 118:89-99.
12. King Victoria L., Hatch Nicholas W., Chan Huei-Wei, de Beer Marcielle C., de Beer Frederick C., Tannock Lisa R. A murine model of obesity with accelerated atherosclerosis. Obesity 2009, 18:35-41.
13. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. 1996, 93(16):8455-8459.
14. Lacy Charles F., Armstrong Lora L., Goldman Morton P., Lance Leonard L. Drug Information Handbook; a Comprehensive Resource for All Clinicians and Healthcare Professionals 2008, Lexi-Comp. 15th ed.
15. Lee D.K., Nathan Grantham R., Trachte A.L., Mannion J.D., Wilson C.L. Activation of the canonical Wnt/beta-catenin pathway enhances monocyte adhesion to endothelial cells. Biochem. Biophys. Res. Commun. 2006, 347:109-116.
16. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
17. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
18. Listenberger L.L., Ory D.S., Schaffer J.E. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem. 2001, 276:14890-14895.
19. Maloney E., Sweet I.R., Hockenbery D.M., Pham M., Rizzo N.O., Tateya S., Handa P., Schwartz M.W., Kim F. Activation of NF-κB by palmitate in endothelial cells a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1370-1375.
20. Martin M., Rehani K., Jope R.S., Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 2005, 6:777-784.
21. Mathew M., Tay E., Cusi K. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects. Cardiovasc. Diabetol. 2010, 9:9. Feb 16.
22. Mittendorfer B., Liem O., Patterson B., Miles J., Klein S. What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean?. Diabetes 2003, 52:1641-1648.
23. Modur V., Zimmerman G.A., Prescott S.M., McIntyre T.M. Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J. Biol. Chem. 1996, 271(22):13094-13102.
24. Nakashima Y., Raines E.W., Plump A.S., Breslow J.L., Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoe-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 1998, 18(5):842-851.
25. Oliveira H.C., Cosso R.G., Alberici L.C., Maciel E.N., Salerno A.G., Dorighello G.G., Velho J.A., de Faria E.C., Vercesi A.E. Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria. FASEB J. 2005, 19:278-280.
26. Osterud B., Bjorklid E. Role of monocytes in atherogenesis. Physiol. Rev. 2003, 83:1069-1112.
27. Paigen B., Morrow A., Holmes P.A., Mitchell D., Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987, 68(3):231-240.
28. Rahman A., Anwar K.N., Malik A.B. Protein kinase C-ζ mediates TNF-α-induced ICAM-1 gene transcription in endothelial cells. Am. J. Physiol. Cell Physiol. 2000, 279:C906-C914.
29. Reusch J.E. Diabetes, microvascular complications, and cardiovascular complications: what is about glucose?. J. Clin. Invest. 2003, 112:986-988.
30. Ross R. Atherosclerosis: an inflammatory disease. N Engl J. Med. 1999, 340:115-126.
31. Stevens H.Y., Melchior B., Bell K.S., Yun S., Yeh J.C., Frangos J.A. PECAM-1 is a critical mediator of atherosclerosis. Dis Model Mech 2008, 1(2-3):175-181.
32. Vines A., Cahoon S., Goldberg I., Saxena U., Pillarisetti S. Novel anti-inflammatory role for glycogen synthase kinase-3βin the inhibition of tumor necrosis factor-α- and interleukin-1β-induced inflammatory gene expression. J. Biol. Chem. 2006, 281:16985-16990.
33. Whittle B.J., Varga C., Pósa A., Molnár A., Collin M., Thiemermann C. Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta. Br. J. Pharmacol. 2006, 147(5):575-582.
34. Wikström J., Grönros J., Bergström G., Gan L.M. Functional and morphologic imaging of coronary atherosclerosis in living mice using high-resolution color doppler echocardiography and ultrasound biomicroscopy. J. Am. Coll. Cardiol. 2005, 46:720-727.
35. Yamashita T., Kawashima S., Ozaki M., Namiki M., Inoue N., Hirata K., Yokoyama M. Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration. Arterioscler. Thromb. Vasc. Biol. 2002, 22:969-974.
36. Yeop Han C., Kargi A.Y., Omer M., Chan C.K., Wabitsch M., O'Brien K.D., Wight T.N., Chait A. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes 2010, 59(2):386-396.
37. Zhang P., Katz J., Michalek S.M. GSK-3β inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice. Mol. Immunol. 2009, 46:677-687.